In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4185-4196

  Ueda, Yutaka ^a   Kanazawa, Katsunori ^a   Eguchi, Ken ^a   Takemoto, Koji ^a   Eriguchi, Yoshiro ^a   Sunagawa, Makoto ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 TETRAHYDROPYRIDINYLTHIAZOL 2 YLTHIO) 1BETA METHYLCARBAPENEM; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CYCLOPHOSPHAMIDE; DALFOPRISTIN PLUS QUINUPRISTIN; FLOMOXEF; IMIPENEM; LINEZOLID; MEROPENEM; OXACILLIN; PANIPENEM; PENICILLIN G; SM 216601; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BINDING AFFINITY; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEPTICEMIA; SERRATIA MARCESCENS; STREPTOCOCCUS PNEUMONIAE;

ABSCESS; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CARBAPENEMS; ENTEROCOCCUS FAECALIS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; INFUSIONS, PARENTERAL; KINETICS; MALE; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; REFERENCE STANDARDS;

EID: 25844432417     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4185-4196.2005     Document Type: Article

References (36)

1. Adachi, H., T. Katayama, C. Inuzuka, S. Oikawa, M. Tsujimoto, and H. Nakazato. 1990. Identification of membrane anchoring site of human renal dipeptidase and construction and expression of a cDNA for its secretory form. J. Biol. Chem. 265:15341-15345.
2. Adachi, Y., K. Nakamura, Y. Kato, N. Hazumi, T. Hashizume, and S. Nakagawa. 1997. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 41:2282-2285.
3. American Thoracic Society. 1995. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am. J. Respir. Crit. Care Med. 153:1711-1725.
4. Arakawa, Y., Y. Ike, M. Nagasawa, N. Shibata, Y. Doi, K. Shibayama, T. Yagi, and T. Kurata. 2000. Trends in antimicrobial-drug resistance in Japan. Emerg. Infect. Dis. 6:572-575.
5. Baquero, F. 1997. Gram-positive resistance: challenge for the development of new antibiotics. J. Antimicrob. Chemother. 39:1-6.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Campbell, B. J. 1970. Renal dipeptidase. Methods Enzymol. 19:722-729.
8. El Amin, N., B. Lund, A. Tjernlund, C. Lundberg, K. Jalakas, and B. Wretlind. 2001. Mechanisms of resistance to imipenem in imipenem-resistant, ampicillin-sensitive Enterococcus faecium. APMIS 109:791-796.
9. Fukasawa, M., Y. Sumita, E. T. Harabe, T. Tanio, H. Nouda, T. Kohzuki, T. Okuda, H. Matsumura, and M. Sunagawa. 1992. Stability of meropenem and effect of 1β-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrob. Agents Chemother. 36:1577-1579.
10. Fukuoka, T., S. Ohya, T. Narita, M. Katsuta, M. Iijima, N. Masuda, H. Yasuda, J. Trias, and H. Nikaido. 1993. Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob. Agents Chemother. 37:322-327.
11. Fung-Tomc, J. C., J. Clark, B. Minassian, M. Pucci, Y. H. Tsai, E. Gradelski, L. Lamb, I. Medina, E. Huczko, B. Kolek, S. Chaniewski, C. Ferraro, T. Washo, and D. P. Bonner. 2002. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci. Antimicrob. Agents Chemother. 46:971-976.
12. Glinka, T. W. 2002. Novel cephalosporins for the treatment of MRSA infections. Curr. Opin. Investig. Drugs 3:206-217.
13. Griffith, D. C., L. Harford, R. Williams, V. J. Lee, and M. N. Dudley. 2003. In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria. Antimicrob. Agents Chemother. 47:43-41.
14. Hanaki, H., H. Akagi, Y. Masaru, T. Otani, A. Hyodo, and K. Hiramatsu. 1995. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1120-1126.
15. Hebeisen, P., I. Heinze-Krauss, P. Angehrn, P. Hohl, M. G. Page, and R. L. Then. 2001. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 45:825-836.
16. Ishikawa, T., N. Matsunaga, H. Tawada, N. Kuroda, Y. Nakayama, Y. Ishibashi, M. Tomimoto, Y. Ikeda, Y. Tagawa, Y. Iizawa, K. Okonogi, S. Hashiguchi, and A. Miyake. 2003. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Bioorg. Med. Chem. 11:2427-2437.
17. Jones, R. N. 2001. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 119:397S-404S.
18. Kohler, T., M. Michea-Hamzehpour, S. F. Epp, and J. C. Pechere. 1999. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents Chemother. 43:424-427.
19. Malanoski, G., L. Collins, C. T. Eliopoulos, R. C. Moellering, Jr., and G. M. Eliopoulos. 1995. Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria. Antimicrob. Agents Chemother. 39:990-995.
20. Muramatsu, H., T. Horii, M. Morita, H. Hashimoto, T. Kanno, and M. Maekawa. 2003. Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates. Int. J. Med. Microbiol. 293:191-197.
21. Nagano, R., K. Shibata, Y. Adachi, H. Imamura, T. Hashizume, and H. Morishima. 2000. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:489-495.
22. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. Shinagawa, H., H. Yamaga, H. Houchigai, Y. Sumita, and M. Sunagawa. 1997. Synthesis and biological properties of a new series of anti-MRSA β-lactams, 2-(thiazol-2-ylthio)carbapenems. Bioorg. Med. Chem. 5:601-621.
24. Sumita, Y., M. Fukasawa, S. Mitsubashi, and M. Inoue. 1995. Binding affinities of β-lactam antibodies for penicillin-binding protein 2′ in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 35:473-481.
25. Sumita, Y., M. Fukasawa, and T. Okuda. 1990. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes. J. Antibiot. 43:314-320.
26. Sumita, Y., H. Nouda, K. Kanazawa, and M. Fukasawa. 1995. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:910-916.
27. Sunagawa, M., M. Itoh, K. Kubota, A. Sasaki, Y. Ueda, P. Angehrn, A. Bourson, E. Goetschi, P. Hebeisen, and R. L. Then. 2002. New anti-MRSA and anti-VRE carbapenems: synthesis and structure-activity relationships of 1β-methyl-2-(thiazol-2-ylthio)carbapenems. J. Antibiot. 55:722-757.
28. Sunagawa, M., A. Sasaki, Y. Sumita, and Y. Ueda. 2002. Recent progress of anti-MRSA carbapenem antibiotic research, p. 75-95. In Recent research developments in antibiotics. Transworld Research Network, Kerala, India.
29. Sunagawa, M., H. Yamaga, H. Shinagawa, H. Houchigai, and Y. Sumita. 1994. Synthesis and biological properties of a new series of anti-MRSA β-lactams, 2-(thiazole-2′-ylthio)carbapenems. Bioorg. Med. Chem. Lett. 4:2793-2798.
30. Trias, J., J. Dufresne, R. C. Levesque, and H. Nikaido. 1989. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 33:1202-1206.
31. Trias, J., and H. Nikaido. 1990. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34:52-57.
32. Trias, J., and H. Nikaido. 1990. Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J. Biol. Chem. 265:15680-15684.
33. Tsuji, M., M. Takema, H. Miwa, J. Shimada, and S. Kuwahara. 2003. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrob. Agents Chemother. 47:2507-2512.
34. Ueda, Y., M. Itoh, A. Sasaki, and M. Sunagawa. 2005. SM-216601, a novel parenteral 1β-methylcarbapenem: structure-activity relationships of antibacterial activity and neurotoxicity in mouse. J. Antibiot. 58:118-140.
35. Ueda, Y., and M. Sunagawa. 2003. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1β-methylcarbapenems with potent activities against multiresistant gram-positive bacteria. Antimicrob. Agents Chemother. 47:2471-2480.
36. Zorzi, W., X. Y. Zhou, O. Dardenne, J. Lamotte, D. Raze, J. Pierre, L. Gutmann, and J. Coyette. 1996. Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type and highly penicillin-resistant strains of Enterococcus faecium. J. Bacteriol. 178:4948-4957.